KRAS and neoplasm: While the aberrant elevation of MLKL levels does not seem to directly orient from KRAS/TP53 mutation, this unique expression pattern leads to a special form of necroptosis in T1M1 tumour cells and is quite different from the expression pattern shown by necroptosis-related molecules in the pancreatic ductal epithelium.